• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

新型冠状病毒肺炎与重症肌无力全身型加重：一例报告

COVID-19 and generalized Myasthenia Gravis exacerbation: A case report.

作者信息

Singh Shivangi, Govindarajan Raghav

机构信息

Department of Neurology, University of Missouri, CE515, CS & E Building, Columbia, MO, 65212, United States.

Department of Neurology, University of Missouri, CE515, CS & E Building, Columbia, MO, 65212, United States.

出版信息

Clin Neurol Neurosurg. 2020 Sep;196:106045. doi: 10.1016/j.clineuro.2020.106045. Epub 2020 Jun 25.

DOI:10.1016/j.clineuro.2020.106045
PMID:32634699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7316067/
Abstract

• MG treatment in the context of COVID-19 should be tailored to the patient. • Patient’s respiratory status should be closely monitored. • Concomitant COVID-19 and MG has a variable response to treatment.

摘要

• 新冠病毒病背景下的重症肌无力治疗应因人而异。

• 应密切监测患者的呼吸状况。

• 新冠病毒病与重症肌无力并存时，治疗反应不一。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1710/7316067/9d21d03b1fd1/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1710/7316067/9d21d03b1fd1/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1710/7316067/9d21d03b1fd1/gr1_lrg.jpg

相似文献

1
COVID-19 and generalized Myasthenia Gravis exacerbation: A case report.新型冠状病毒肺炎与重症肌无力全身型加重：一例报告
Clin Neurol Neurosurg. 2020 Sep;196:106045. doi: 10.1016/j.clineuro.2020.106045. Epub 2020 Jun 25.
2
COVID-19 in patients with myasthenia gravis.COVID-19 与重症肌无力。
Muscle Nerve. 2020 Aug;62(2):254-258. doi: 10.1002/mus.26918. Epub 2020 May 22.
3
Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.新型冠状病毒肺炎（COVID-19）大流行期间重症肌无力（MG）和兰伯特-伊顿肌无力综合征（LEMS）的管理指南。
J Neurol Sci. 2020 May 15;412:116803. doi: 10.1016/j.jns.2020.116803. Epub 2020 Mar 25.
4
Clinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection.临床推理：新型冠状病毒肺炎感染所致重症肌无力危象的治疗考量
Neurology. 2020 Nov 3;95(18):840-843. doi: 10.1212/WNL.0000000000010651. Epub 2020 Aug 14.
5
The characterization of chronic rhinosinusitis in hospitalized patients with COVID-19.新冠病毒感染住院患者慢性鼻-鼻窦炎的特征
J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3597-3599.e2. doi: 10.1016/j.jaip.2020.09.013. Epub 2020 Sep 24.
6
Optimal therapeutic strategy using extracorporeal membrane oxygenation in patients with COVID-19.新型冠状病毒肺炎患者使用体外膜肺氧合的最佳治疗策略
J Card Surg. 2020 Oct;35(10):2872-2873. doi: 10.1111/jocs.14831.
7
Dysphagia and Dysphonia, a Pairing of Symptoms Caused by an Unusual Pair of Diseases: Castleman's Disease and Myasthenia Gravis.吞咽困难和发声困难，一对由不常见疾病引起的症状：Castleman 病和重症肌无力。
Ann Otol Rhinol Laryngol. 2021 Mar;130(3):319-324. doi: 10.1177/0003489420949581. Epub 2020 Aug 19.
8
Oxygenation device with reservoir and PEEP (ODRPEEP) in patients with acute respiratory distress due to COVID-19.用于新型冠状病毒肺炎所致急性呼吸窘迫患者的带储液器和呼气末正压的氧合装置（ODRPEEP）
Med Clin (Barc). 2020 Aug 14;155(3):133-134. doi: 10.1016/j.medcli.2020.04.010. Epub 2020 May 8.
9
Awake proning in Covid-19 pneumonia.新型冠状病毒肺炎的清醒俯卧位通气
Infez Med. 2020 Sep 1;28(3):453-455.
10
COVID-19-related encephalopathy responsive to high-dose glucocorticoids.对大剂量糖皮质激素有反应的新型冠状病毒肺炎相关脑病
Neurology. 2020 Sep 22;95(12):543-546. doi: 10.1212/WNL.0000000000010354. Epub 2020 Jul 17.

引用本文的文献

1
Evaluation of Clinical Effects of COVID-19 Infection and Vaccines on Myasthenia Gravis.新型冠状病毒肺炎感染及疫苗对重症肌无力临床影响的评估
Noro Psikiyatr Ars. 2024 Aug 19;67(3):213-220. doi: 10.29399/npa.28418. eCollection 2024.
2
Predictive Factors for Poor Outcomes Associated with COVID-19 in a Retrospective Cohort of Myasthenia Gravis Patients.重症肌无力患者回顾性队列中与COVID-19相关的不良预后预测因素
J Inflamm Res. 2024 Aug 29;17:5807-5820. doi: 10.2147/JIR.S475729. eCollection 2024.
3
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study.

本文引用的文献

1
COVID-19 in patients with myasthenia gravis.COVID-19 与重症肌无力。
Muscle Nerve. 2020 Aug;62(2):254-258. doi: 10.1002/mus.26918. Epub 2020 May 22.
2
Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network.法国罕见神经肌肉疾病护理网络在 COVID-19 大流行期间对神经肌肉患者护理的指导意见。
Rev Neurol (Paris). 2020 Jun;176(6):507-515. doi: 10.1016/j.neurol.2020.04.004. Epub 2020 Apr 20.
3
Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.
齐卢可普兰治疗全身型重症肌无力患者的长期安全性和有效性：RAISE-XT开放标签扩展研究的中期分析
Ther Adv Neurol Disord. 2024 Apr 17;17:17562864241243186. doi: 10.1177/17562864241243186. eCollection 2024.
4
A Case Report and Literature Review of New-Onset Myasthenia Gravis After COVID-19 Infection.新冠病毒感染后新发重症肌无力的病例报告及文献综述
Cureus. 2022 Dec 28;14(12):e33048. doi: 10.7759/cureus.33048. eCollection 2022 Dec.
5
A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases.COVID-19 症状和治疗在自身免疫性疾病中的全面综述。
Virol J. 2023 Jan 7;20(1):1. doi: 10.1186/s12985-023-01967-7.
6
SARS-CoV-2 vaccination and new-onset myasthenia gravis: A report of 7 cases and review of the literature.SARS-CoV-2 疫苗接种与重症肌无力新发病例：7 例报告及文献复习。
Neuromuscul Disord. 2022 Oct;32(10):785-789. doi: 10.1016/j.nmd.2022.09.001. Epub 2022 Sep 5.
7
The relationship between myasthenia gravis and COVID-19: a systematic review.重症肌无力与2019冠状病毒病的关系：一项系统综述。
Egypt J Neurol Psychiatr Neurosurg. 2022;58(1):83. doi: 10.1186/s41983-022-00516-3. Epub 2022 Jul 7.
8
Acute neuromuscular syndromes with respiratory failure during COVID-19 pandemic: Where we stand and challenges ahead.急性神经肌肉综合征伴 COVID-19 大流行期间呼吸衰竭：现状与未来挑战。
J Clin Neurosci. 2022 Jul;101:264-275. doi: 10.1016/j.jocn.2022.03.048. Epub 2022 Apr 29.
9
Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients.疫苗与重症肌无力：对一大群重症肌无力患者进行的 SARS-CoV-2 疫苗接种的全面回顾性研究。
J Neurol. 2022 Aug;269(8):3965-3981. doi: 10.1007/s00415-022-11140-9. Epub 2022 May 3.
10
COVID-19 Outcomes in Myasthenia Gravis Patients: Analysis From Electronic Health Records in the United States.重症肌无力患者的新冠病毒病结局：来自美国电子健康记录的分析
Front Neurol. 2022 Mar 28;13:802559. doi: 10.3389/fneur.2022.802559. eCollection 2022.
新型冠状病毒肺炎（COVID-19）大流行期间重症肌无力（MG）和兰伯特-伊顿肌无力综合征（LEMS）的管理指南。
J Neurol Sci. 2020 May 15;412:116803. doi: 10.1016/j.jns.2020.116803. Epub 2020 Mar 25.
4
International consensus guidance for management of myasthenia gravis: Executive summary.重症肌无力管理的国际共识指南：执行摘要。
Neurology. 2016 Jul 26;87(4):419-25. doi: 10.1212/WNL.0000000000002790. Epub 2016 Jun 29.